<DOC>
	<DOCNO>NCT02388464</DOCNO>
	<brief_summary>This Phase 1 , single-center , randomize , double-blind , single ascend dose , placebo-controlled study , subject age 45-80 year stable mild moderate heart failure due leave ventricular systolic dysfunction , evaluate safety , tolerability , pharmacokinetics escalate single intravenous infusion dos Bendavia™ ( MTP-131 ) .</brief_summary>
	<brief_title>A Study Investigating Safety , Tolerability , Pharmacokinetics MTP-131 Subjects With Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Chronic ischemic nonischemic cardiomyopathy least 6 month duration time initial diagnosis . LVEF ≤35 % 2D echocardiogram . Diagnosis NYHA Class II III HF minimum 6 month prior Screening Visit . HF consider stable hospitalization HF occur within previous 3 month prior Screening visit . Treatment appropriate pharmacologic therapy HF include , limited , angiotensin convert enzyme inhibitor ( ACEI ) and/or angiotensin receptor blocker ( ARB ) , evidencebased beta blocker treatment HF ( i.e . carvedilol , bisoprolol , extendedrelease metoprolol ) . Dose dose regimen pharmacologic treatment HF must stable minimum 1 month prior Screening Visit . Females childbearing potential must negative serum pregnancy test Screening Visit Day 1 . LV enddiastolic dimension ( LVEDD ) , method qualify LVEF , &gt; 80 mm LVEDD index body surface area &gt; 0.45 . Unstable angina pectoris within 1 month initiation screening procedure . Unstable angina define occurrence chest pain frequently usual , pain rest upon minimal exertion , protract episode pain without discernible trigger , and/or chest pain persist despite use vasodilatory therapy ( e.g. , nitroglycerin ) . Coronary peripheral artery revascularization procedure within 2 month prior Screening Visit . An acute myocardial infarction within 3 month prior Screening Visit . Placement automate implantable cardioverter defibrillator ( AICD ) hardware associate resynchronization therapy . Atrial fibrillation Screening Baseline Visits . Uncontrolled hypertension define systolic blood pressure ( BP ) &gt; 180 mm Hg diastolic BP &gt; 110 mm Hg least 2 consecutive reading . Requirement valve cardiac surgery Cardiac surgery valvuloplasty within 2 month prior Screening Visit . General surgery within 1 month prior Screening Visit Restrictive cardiomyopathy , obstructive cardiomyopathy , pericardial disease , amyloidosis , infiltrative cardiomyopathy , uncorrected thyroid disease , dyskinetic leave ventricular aneurysm . Cerebrovascular accident transient ischemic attack within 3 month prior Screening Visit . Estimated glomerular filtration rate ( eGFR ) &lt; 40 mL/min , use Modification Diet Renal Disease ( MDRD ) Study equation Serologic evidence hepatitis B C infection . Known acquired immunodeficiency syndrome HIVpositive status , diagnosis immunodeficiency . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Bendavia™</keyword>
	<keyword>MTP-131</keyword>
</DOC>